Alimentary Pharmacology and Therapeutics, 0269-2813

Journal

More filtering options
  1. 2020
  2. Healthcare use, work loss and total costs in incident and prevalent Crohn's disease and ulcerative colitis: results from a nationwide study in Sweden

    Olof Grip & SWIBREG Study Group SWIBREG Study Group, 2020 Jan 1, (Accepted/In press) In : Alimentary Pharmacology and Therapeutics.

    Research output: Contribution to journalArticle

  3. 2019
  4. Letter: different risks of venous thromboembolism in subsets of patients with inflammatory bowel diseases

    Ru Ding, Jianjiang Xu, Zhiqing He, Yihong Chen, Anna Hultgårdh-Nilsson & Chun Liang, 2019, In : Alimentary Pharmacology and Therapeutics. 49, 3, p. 345-346 2 p.

    Research output: Contribution to journalLetter

  5. 2017
  6. Letter: how to define remission in ulcerative colitis – histological remission should be considered. Authors' reply

    L. Angelison, J. Marsal & E. Hertervig, 2017 Apr 1, In : Alimentary Pharmacology and Therapeutics. 45, 8, p. 1177-1178 2 p.

    Research output: Contribution to journalLetter

  7. Long-term outcome of infliximab treatment in chronic active ulcerative colitis: a Swedish multicentre study of 250 patients

    Leif Angelison, S. Almer, A. Eriksson, P. Karling, U. Fagerberg, J. Halfvarson, M. Thörn, J. Björk, U. Hindorf, R. Löfberg, A. Bajor, H. Hjortswang, P. Hammarlund, O. Grip, J. Torp, J. Marsal & E. Hertervig, 2017 Feb 1, In : Alimentary Pharmacology and Therapeutics. 45, 4, p. 519-532 14 p.

    Research output: Contribution to journalArticle

  8. 2016
  9. Incidence, clinical presentation and mortality of liver cirrhosis in Southern Sweden: A 10-year population-based study

    EMMA NILSSON, H. Anderson, K. Sargenti, S. Lindgren & H. Prytz, 2016 Jun 1, In : Alimentary pharmacology & therapeutics. 43, 12, p. 1330-1339 10 p.

    Research output: Contribution to journalArticle

  10. 2014
  11. Association between high dietary intake of the n-3 polyunsaturated fatty acid docosahexaenoic acid and reduced risk of Crohn's disease

    S. S. M. Chan, R. Luben, A. Olsen, A. Tjonneland, R. Kaaks, Stefan Lindgren, Olof Grip, M. M. Bergmann, H. Boeing, G. Hallmans, P. Karling, K. Overvad, S. K. Veno, F. van Schaik, B. Bueno-de-Mesquita, B. Oldenburg, K. -T. Khaw, E. Riboli & A. R. Hart, 2014, In : Alimentary pharmacology & therapeutics. 39, 8, p. 834-842

    Research output: Contribution to journalArticle

  12. Letter: European Medicines Agency recommendations for allergic reactions to intravenous iron-containing medicines

    F. Gomollon, Y. Chowers, S. Danese, A. Dignass, O. Haagen Nielsen, P. L. Lakatos, C. W. Lees, Stefan Lindgren, M. Lukas, G. J. Mantzaris, P. Michetti, B. Moum, L. Peyrin-Biroulet, M. Toruner, J. van der Woude, G. Weiss, H. Stoevelaar & W. Reinisch, 2014, In : Alimentary pharmacology & therapeutics. 39, 7, p. 743-744

    Research output: Contribution to journalLetter

  13. 2013
  14. Infliximab as rescue therapy in hospitalised patients with steroid-refractory acute ulcerative colitis: a long-term follow-up of 211 Swedish patients

    M. Sjoberg, A. Magnuson, J. Bjork, Cecilia Benoni, S. Almer, I. Friis-Liby, Erik Hertervig, M. Olsson, P. Karlen, A. Eriksson, G. Midhagen, M. Carlson, A. Lapidus, J. Halfvarson & C. Tysk, 2013, In : Alimentary pharmacology & therapeutics. 38, 4, p. 377-387

    Research output: Contribution to journalArticle

  15. The management of iron deficiency in inflammatory bowel disease - an online tool developed by the RAND/UCLA appropriateness method

    W. Reinisch, Y. Chowers, S. Danese, A. Dignass, F. Gomollon, O. Haagen Nielsen, P. L. Lakatos, C. W. Lees, Stefan Lindgren, M. Lukas, G. J. Mantzaris, P. Michetti, B. Moum, L. Peyrin-Biroulet, M. Toruner, J. van der Woude, G. Weiss & H. Stoevelaar, 2013, In : Alimentary pharmacology & therapeutics. 38, 9, p. 1109-1118

    Research output: Contribution to journalArticle

  16. 2012
  17. Fatigue in out-patients with inflammatory bowel disease is common and multifactorial.

    P Bager, R Befrits, O Wikman, Stefan Lindgren, B Moum, H Hjortswang, N H Hjollund & J F Dahlerup, 2012, In : Alimentary pharmacology & therapeutics. 35, p. 133-141

    Research output: Contribution to journalArticle

  18. High dose ursodeoxycholic acid in primary sclerosing cholangitis does not prevent colorectal neoplasia

    L. Lindstrom, K. M. Boberg, O. Wikman, I. Friis-Liby, R. Hultcrantz, Hanne Prytz, H. Sandberg-Gertzen, P. Sangfelt, A. Rydning, G. Folvik, M. Gangsoy-Kristiansen, A. Danielsson & Annika Bergquist, 2012, In : Alimentary pharmacology & therapeutics. 35, 4, p. 451-457

    Research output: Contribution to journalArticle

  19. 2011
  20. Hospitalisation of and mortality from bleeding peptic ulcer in Sweden: a nationwide time-trend analysis.

    Kristina Åhsberg, W Ye, Y Lu, Z Zheng & Christer Staël von Holstein, 2011, In : Alimentary pharmacology & therapeutics. 33, 5, p. 578-584

    Research output: Contribution to journalArticle

  21. 2010
  22. The epidemiology and clinical features of portal vein thrombosis: A multicentre study

    R. Rajani, E. Björnsson, A. Bergquist, Å Danielsson, A. Gustavsson, O. Grip, T. Melin, P. Sangfelt, S. Wallerstedt & S. Almer, 2010 Nov 1, In : Alimentary Pharmacology and Therapeutics. 32, 9, p. 1154-1162 9 p.

    Research output: Contribution to journalArticle

  23. Clinical trial: colectomy after rescue therapy in ulcerative colitis-3-year follow-up of the Swedish-Danish controlled infliximab study

    A. Gustavsson, G. Jarnerot, Erik Hertervig, I. Friis-Liby, L. Blomquist, P. Karlen, C. Granno, M. Vilien, M. Strom, Hans Verbaan, P. M. Hellstrom, A. Magnuson, J. Halfvarson & C. Tysk, 2010, In : Alimentary pharmacology & therapeutics. 32, 8, p. 984-989

    Research output: Contribution to journalArticle

  24. Mortality from peptic ulcer bleeding: the impact of comorbidity and the use of drugs that promote bleeding.

    Kristina Åhsberg, Peter Höglund & Christer Staël von Holstein, 2010, In : Alimentary pharmacology & therapeutics. 32, p. 801-810

    Research output: Contribution to journalArticle

  25. 2009
  26. Bleeding peptic ulcer - time trends in incidence, treatment and mortality in Sweden.

    Jalal Sadic, Anders Borgström, Jonas Manjer, Ervin Toth & Gert Lindell, 2009, In : Alimentary pharmacology & therapeutics. 30, p. 392-398

    Research output: Contribution to journalArticle

  27. Clinical trial: B vitamins improve health in patients with coeliac disease living on a gluten-free diet

    C. Hallert, M. Svensson, J. Tholstrup & Björn Hultberg, 2009, In : Alimentary pharmacology & therapeutics. 29, 8, p. 811-816

    Research output: Contribution to journalArticle

  28. Mercaptopurine treatment should be considered in azathioprine intolerant patients with inflammatory bowel disease.

    Ulf Hindorf, M Johansson, A Eriksson, E Kvifors & S H C Almer, 2009, In : Alimentary pharmacology & therapeutics. 29, 6, p. 654-661

    Research output: Contribution to journalArticle

  29. 2006
  30. Adverse events leading to modification of therapy in a large cohort of patients with inflammatory bowel disease.

    Ulf Hindorf, M Lindqvist, H Hildebrand, U Fagerberg & S Almer, 2006, In : Alimentary pharmacology & therapeutics. 24, 2, p. 331-342

    Research output: Contribution to journalArticle

  31. 2005
  32. Daily treatment with esomeprazole is superior to that taken on demand for maintenance of healed erosive esophagitis

    S Sjöstedt, R Befrits, A Sylvan, L Carling, C Harthon, S Modin, A Stubberöd & Ervin Toth, 2005, In : Alimentary pharmacology & therapeutics. 22, 3, p. 183-191

    Research output: Contribution to journalArticle

  33. 2004
  34. Helicobacter species in human colon biopsies

    Erik Sturegård, Erik Hertervig, Håkan Sjunnesson & Torkel Wadström, 2004, In : Alimentary pharmacology & therapeutics. 19, 5, p. 613-614

    Research output: Contribution to journalLetter

  35. 2003
  36. A pharmacoscintigraphic evaluation of oral budesonide given as controlled-release (Entocort) capsules.

    S. Edsbäcker, B. Bengtsson, P. Larsson, P. Lundin, A Nilsson, J. Ulmius & Per Wollmer, 2003, In : Alimentary pharmacology & therapeutics. 17, 4, p. 525-536

    Research output: Contribution to journalArticle

  37. 2000
  38. Allopurinol in addition to 5-aminosalicylic acid based drugs for the maintenance treatment of ulcerative colitis

    G Järnerot, M Ström, A Danielsson, A Kilander, L Lööf, R Hultcrantz, R Löfberg, C Florén, A Nilsson & O Broström, 2000 Sep, In : Alimentary pharmacology & therapeutics. 14, 9, p. 1159-62 4 p.

    Research output: Contribution to journalArticle

  39. 1994
  40. Pharmacokinetics and retrograde spread of budesonide enemas in patients with distal ulcerative colitis

    Margareta Nyman-Pantelidis, Åke Nilsson, Zoltan Wagner & Olof Borgå, 1994 Dec 1, In : Alimentary Pharmacology and Therapeutics. 8, 6, p. 617-622

    Research output: Contribution to journalArticle

  41. 1993
  42. Pharmacokinetics of budesonide enema in patients with distal ulcerative colitis or proctitis

    Åke Danielsson, Staffan Edsbäcker, Robert Löfberg, Åke Nilsson, Margareta Nyman-Pantelidis, Olle Olsson, Ole Suhr & Roger Willeń, 1993 Aug 1, In : Alimentary Pharmacology and Therapeutics. 7, 4, p. 401-407

    Research output: Contribution to journalArticle